Huge Setback for Covaxin, FDA didn’t allow emergency use of Covaxin
New Delhi, 11/6 (Ao Bureau): Bharat Biotech’s corona vaccine ‘Covaxin’ has suffered a setback. The US has refused to grant Emergency Use Approval (EUA) to this vaccine. It is being said that this decision has been taken due to lack of complete data. The US Food and Drug Regulator (FDA) has advised its US partner,…
